repligen
report
third
quarter
financial
results
webcast
conference
call
held
thursday
november
est
waltham
globe
newswire
repligen
corporation
nasdaq
rgen
today
announced
company
report
third
quarter
financial
results
thursday
november
company
issue
press
release
market
opens
host
conference
call
est
discuss
business
updates
financial
results
month
reporting
periods
ended
september
conference
call
accessible
dialing
domestic
callers
international
callers
passcode
required
live
call
addition
webcast
accessible
via
investor
relations
section
company
website
conference
call
webcast
archived
period
time
following
live
event
replay
numbers
callers
callers
canada
international
callers
replay
listeners
must
provide
passcode
repligen
corporation
repligen
corporation
global
life
sciences
company
develops
commercializes
highly
innovative
bioprocessing
technologies
systems
increase
efficiencies
process
manufacturing
biological
drugs
inspiring
advances
bioprocessing
customers
serve
primarily
biopharmaceutical
drug
developers
contract
development
manufacturing
organizations
cdmos
worldwide
corporate
headquarters
located
waltham
usa
additional
administrative
manufacturing
operations
marlborough
bridgewater
nj
rancho
dominguez
ca
clifton
park
ny
lund
sweden
breda
netherlands
ravensburg
germany
press
release
may
contain
statements
within
meaning
federal
securities
laws
investors
cautioned
statements
press
release
strictly
historical
statements
including
without
limitation
statements
identified
words
like
believe
expect
may
seek
could
similar
expressions
constitute
statements
statements
subject
number
risks
uncertainties
could
cause
actual
results
differ
materially
anticipated
including
risks
discussed
time
time
filings
securities
exchange
commission
expressly
disclaim
responsibility
update
statements
except
required
law
repligen
contact
sondra
newman
global
head
investor
relations
investors
